| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/18/2023 | 39.59% | Redburn Atlantic | → $11 | Initiates Coverage On | → Buy |
| 10/16/2023 | 37.06% | Jefferies | → $10.8 | Initiates Coverage On | → Buy |
| 10/05/2023 | 2.79% | New Street Research | $8.25 → $8.1 | Downgrades | Buy → Neutral |
| 09/11/2023 | 14.21% | JP Morgan | → $9 | Upgrades | Neutral → Overweight |
| 08/21/2023 | 18.02% | UBS | $8.5 → $9.3 | Maintains | Buy |
| 06/06/2023 | 7.87% | UBS | $7 → $8.5 | Maintains | Buy |
| 05/18/2023 | -22.59% | Citigroup | $7 → $6.1 | Downgrades | Buy → Neutral |
| 05/16/2023 | -11.17% | B of A Securities | $5.5 → $7 | Maintains | Neutral |
| 03/01/2023 | 1.52% | Goldman Sachs | $9 → $8 | Maintains | Buy |
| 02/09/2023 | -23.86% | Keybanc | $5 → $6 | Maintains | Overweight |
| 01/09/2023 | -36.55% | Keybanc | $6 → $5 | Maintains | Overweight |
| 12/08/2022 | — | JP Morgan | Upgrades | Underweight → Neutral | |
| 12/06/2022 | 20.56% | Goldman Sachs | $11 → $9.5 | Maintains | Buy |
| 11/11/2022 | — | JP Morgan | Downgrades | Neutral → Underweight | |
| 07/25/2022 | -11.17% | Citigroup | $9 → $7 | Maintains | Buy |
| 07/18/2022 | -11.17% | New Street Research | → $7 | Upgrades | Neutral → Buy |
| 07/06/2022 | -11.17% | New Street Research | $9 → $7 | Maintains | Neutral |
| 05/13/2022 | -23.86% | Keybanc | $12 → $6 | Maintains | Overweight |
| 04/05/2022 | 39.59% | MoffettNathanson | → $11 | Initiates Coverage On | → Buy |
| 01/28/2022 | -4.82% | B of A Securities | → $7.5 | Initiates Coverage On | → Neutral |
| 01/05/2022 | — | Itau BBA | Initiates Coverage On | → Underperform | |
| 01/04/2022 | 52.28% | Citigroup | → $12 | Initiates Coverage On | → Buy |
| 01/04/2022 | 26.9% | JP Morgan | → $10 | Initiates Coverage On | → Neutral |
| 01/03/2022 | 64.97% | Wolfe Research | → $13 | Initiates Coverage On | → Outperform |
| 01/03/2022 | 77.66% | Susquehanna | → $14 | Initiates Coverage On | → Positive |
| 01/03/2022 | 103.05% | Morgan Stanley | → $16 | Initiates Coverage On | → Overweight |
| 01/03/2022 | 58.63% | UBS | → $12.5 | Initiates Coverage On | → Buy |
| 01/03/2022 | 26.9% | HSBC | → $10 | Initiates Coverage On | → Hold |
| 01/03/2022 | 90.36% | Goldman Sachs | → $15 | Initiates Coverage On | → Buy |
| 01/03/2022 | 52.28% | Keybanc | → $12 | Initiates Coverage On | → Overweight |
What is the target price for Nu Holdings (NU)?
The latest price target for Nu Holdings (NYSE: NU) was reported by Redburn Atlantic on October 18, 2023. The analyst firm set a price target for $11.00 expecting NU to rise to within 12 months (a possible 39.59% upside). 14 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Nu Holdings (NU)?
The latest analyst rating for Nu Holdings (NYSE: NU) was provided by Redburn Atlantic, and Nu Holdings initiated their buy rating.
When is the next analyst rating going to be posted or updated for Nu Holdings (NU)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Nu Holdings, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Nu Holdings was filed on October 18, 2023 so you should expect the next rating to be made available sometime around October 18, 2024.
Is the Analyst Rating Nu Holdings (NU) correct?
While ratings are subjective and will change, the latest Nu Holdings (NU) rating was a initiated with a price target of $0.00 to $11.00. The current price Nu Holdings (NU) is trading at is $7.88, which is within the analyst's predicted range.